- Home
- NEXA vs XOMAO Comparison
NEXA vs XOMAO Comparison
Compare NEXA & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXA
- XOMAO
- Stock Information
- Founded
- NEXA 1956
- XOMAO N/A
- Country
- NEXA Luxembourg
- XOMAO United States
- Employees
- NEXA N/A
- XOMAO 13
- Industry
- NEXA Metal Mining
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- NEXA Basic Materials
- XOMAO Health Care
- Exchange
- NEXA Nasdaq
- XOMAO Nasdaq
- Market Cap
- NEXA N/A
- XOMAO N/A
- IPO Year
- NEXA 2017
- XOMAO N/A
- Fundamental
- Price
- NEXA $7.80
- XOMAO $25.47
- Analyst Decision
- NEXA Sell
- XOMAO
- Analyst Count
- NEXA 5
- XOMAO 0
- Target Price
- NEXA $7.15
- XOMAO N/A
- AVG Volume (30 Days)
- NEXA 33.3K
- XOMAO N/A
- Earning Date
- NEXA 10-31-2024
- XOMAO N/A
- Dividend Yield
- NEXA N/A
- XOMAO N/A
- EPS Growth
- NEXA N/A
- XOMAO N/A
- EPS
- NEXA N/A
- XOMAO N/A
- Revenue
- NEXA $2,655,440,000.00
- XOMAO N/A
- Revenue This Year
- NEXA $5.66
- XOMAO N/A
- Revenue Next Year
- NEXA N/A
- XOMAO N/A
- P/E Ratio
- NEXA N/A
- XOMAO N/A
- Revenue Growth
- NEXA N/A
- XOMAO N/A
- 52 Week Low
- NEXA $5.10
- XOMAO N/A
- 52 Week High
- NEXA $8.09
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- NEXA 53.69
- XOMAO 41.89
- Support Level
- NEXA $7.40
- XOMAO $25.52
- Resistance Level
- NEXA $7.87
- XOMAO $25.65
- Average True Range (ATR)
- NEXA 0.28
- XOMAO 0.11
- MACD
- NEXA -0.04
- XOMAO -0.02
- Stochastic Oscillator
- NEXA 57.97
- XOMAO 37.40
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.